Eisai Co., Ltd.

MUN:EII0 주식 보고서

시가총액: €14.5b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Eisai 과거 수익 실적

과거 기준 확인 0/6

주요 정보

-5.1%

수익 성장률

-5.1%

EPS 성장률

Pharmaceuticals 산업 성장7.3%
매출 성장률4.7%
자기자본 수익률3.4%
순이익3.6%
최근 수익 업데이트31 Dec 2022

최근 과거 실적 업데이트

업데이트 없음

Recent updates

수익 및 비용 분석

Eisai 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

MUN:EII0 수익, 비용 및 수입 (JPY Millions )
날짜수익수익G+A 비용R&D 비용
31 Dec 22737,09826,705373,875169,848
30 Sep 22752,50032,233382,752173,324
30 Jun 22741,59432,690374,428168,422
31 Mar 22756,22647,954356,847171,738
31 Dec 21712,93557,311317,150165,418
30 Sep 21691,25062,508293,153162,699
30 Jun 21679,25359,855282,369161,584
31 Mar 21645,94242,119272,568150,299
31 Dec 20707,88893,682271,476145,248
30 Sep 20713,400120,571261,973139,628
30 Jun 20707,203124,523253,516141,217
31 Mar 20695,621121,767248,554140,116
31 Dec 19661,64696,659244,091146,367
30 Sep 19631,97457,725239,503147,863
30 Jun 19643,53172,747233,180140,143
31 Mar 19642,83463,386223,798144,844
31 Dec 18627,36763,714212,469139,100
30 Sep 18625,10665,679195,229138,461
30 Jun 18611,49954,347186,198140,514
31 Mar 18600,05451,845179,915139,579
31 Dec 17569,81429,048178,312134,955
30 Sep 17554,27630,269178,090123,639
30 Jun 17544,02729,425176,249119,503
31 Mar 17539,09739,358175,633112,478
31 Dec 16530,69655,031175,240110,471
30 Sep 16542,31371,812178,825114,420
30 Jun 16545,60269,227182,036115,750
31 Mar 16547,92254,933188,227122,307

양질의 수익: EII0 has a large one-off gain of ¥13.4B impacting its last 12 months of financial results to December 31 2022.

이익 마진 증가: EII0's current net profit margins (3.6%) are lower than last year (8%).

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: EII0's earnings have declined by 5.1% per year over the past 5 years.

성장 가속화: EII0's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

수익 대 산업: EII0 had negative earnings growth (-53.4%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (21.1%).

자기자본 수익률

높은 ROE: EII0's Return on Equity (3.4%) is considered low.

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기

7D

1Y

7D

1Y

7D

1Y